The effectiveness of this combination therapy indicates its potential to target CALCA-related pathways or their downstream mediators that are vital for tumor advancement, thereby underscoring the prospective clinical significance of this combinatorial approach for patients suffering from CALCA-deficient neuroendocrine tumors. Here, CALCA is linked to neoplasm.